Menu
Not yet recruiting NCT03924778

Modifying Diet to Improve Gut Microbiome

No phase Interventional Obesity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: DASH diet, standard American diet.
Who it may be relevant to
Registry conditions: Obesity. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Modifying Diet and the Gut Microbiota to Reduce Obesity and Health Disparities

Overview

The investigators will conduct a 2-arm randomized controlled pilot, feasibility feeding study in which 28 participants will be randomized to receive either a calorie-restricted Dietary Approaches to Stop Hypertension (DASH) diet or a calorie-restricted standard American diet provided by the study for 4 weeks. Participants will be non-Hispanic black or white, generally healthy females (14 black, 14 white). The investigators will collect fecal samples at multiple time points before, during, and after the dietary intervention to analyze for changes in the gut microbiota and functional-level metabolic products. This work will be led by an interdisciplinary team including expertise in bio-behavioral science, microbiology, nutrition science, bioinformatics, and biostatistics all with cross-cutting expertise in health disparities, prevention research, nutrition, the gut microbiota, inflammation and other biomarkers. The rationale for the proposed research is that once the interactions between race, diet, and the gut microbiota are more fully understood, targeted diet modifications may provide new and innovative approaches for the prevention and treatment of obesity and obesity-related diseases.

Interventions

  • Behavioral DASH diet
    brief description
  • Behavioral standard American diet
    describe

Primary outcome measures

  • Mean Weight Change of Participants [Time frame: Baseline to day 28]
  • Mean Weight Change of Participants [Time frame: Day 28 to Day 42]
  • Mean Weight Change of Participants [Time frame: Baseline to day 42]
  • Diet-specific changes in secondary bile acid [Time frame: Baseline to day 28]
  • Diet-specific changes in secondary bile acid [Time frame: day 28 to day 42]
  • Diet-specific changes in secondary bile acid [Time frame: baseline to day 42]
  • Diet-specific changes in inflammatory marker [Time frame: baseline to day 28]
  • Diet-specific changes in inflammatory marker [Time frame: day 28 to day 42]
  • Diet-specific changes in inflammatory marker [Time frame: baseline to day 42]
  • Diet-specific changes in short chain fatty acids [Time frame: baseline to day 28]

Eligibility criteria

Inclusion criteria

  • female
  • non-Hispanic, black or white
  • age 19-65 years
  • BMI >= 30 kg/m\^2
  • able to visit Bionutrition Unit daily

Exclusion criteria

  • gastrointestinal (GI) conditions i.e., irritable bowel, diverticulitis, peptic ulcers, Crohn's, GI cancers, and adenatomous polyps
  • antibiotic or probiotic use in the previous 90 days
  • tobacco use
  • heavy alcohol consumption
  • major medical conditions (e.g., renal disease, diabetes, cancer)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Moffit Cancer Center — Tampa

Identifiers

NCT: NCT03924778 · IRB-300003207

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗